Oil or Water-Based Contrast for Hysterosalpingography?
BACKGROUND AND PURPOSE:
Following hysterosalpingography (HSG), infertile women often see increased rates of pregnancy
Oil-based HSG has been associated with increased pregnancy rates
Tubal ‘flushing’ has been hypothesized as the mechanism for this beneficial effect and/or peritoneal macrophage activity
Because the literature has been inconsistent with limited high quality studies, Dreyer et al. (NEJM, 2017) sought to determine if the type of contrast does impact pregnancy rates following diagnostic HSG
Randomized Controlled Trial (RCT)
The trial could not be blinded due to procedural differences
1,119 infertile women undergoing HSG were included
557 women were randomized to receive oil contrast
562 women were randomized to receive water contrast
Following the procedure women either received expectant management or underwent intrauterine insemination based on clinical indications such as male infertility
Primary outcome for this study was a positive fetal heartbeat > 12 weeks within 6 months after randomization
There was no statistical difference between the two groups with regard to bilateral tubal patency, nor the percent of women undergoing IVF
39.7% (220/554) of women in the oil group had an ongoing pregnancy compared to 29.1% (161/554) in the water group (rate ratio, 1.37; 95% CI 1.16 to 1.61; P<0.001)
Women in the oil group 38.8% (214/552) also had higher rates of live births compared to 28.1% (155/552) in the water group (rate ratio, 1.38; 95% CI 1.17 to 1.64; P<0.001)
The 10% increase in clinical pregnancy rate with oil corresponds with a number needed to treat of 10.
Hysterosalpingography with oil contrast leads to an increased chance of ongoing pregnancy at 12 weeks and a higher rate of live births
Please sign up or log in to your ObGFirst to access this Premium Content
Media - Internet
Computer System Requirements
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
NOT ENOUGH CME HOURS
It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan